Literature DB >> 21135976

Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteins.

Ye Hu1, Yang Peng, Kevin Lin, Haifa Shen, Louis C Brousseau, Jason Sakamoto, Tong Sun, Mauro Ferrari.   

Abstract

Phosphorylated peptides and proteins play an important role in normal cellular activities, e.g., gene expression, mitosis, differentiation, proliferation, and apoptosis, as well as tumor initiation, progression and metastasis. However, technical hurdles hinder the use of common fractionation methods to capture phosphopeptides from complex biological fluids such as human sera. Herein, we present the development of a dual strategy material that offers enhanced capture of low molecular weight phosphoproteins: mesoporous silica thin films with precisely engineered pore sizes that sterically select for molecular size combined with chemically selective surface modifications (i.e. Ga3+, Ti4+ and Zr4+) that target phosphoroproteins. These materials provide high reproducibility (CV=18%) and increase the stability of the captured proteins by excluding degrading enzymes, such as trypsin. The chemical and physical properties of the composite mesoporous thin films were characterized by X-ray diffraction, transmission electron microscopy, X-ray photoelectron spectroscopy, energy dispersive X-ray spectroscopy and ellipsometry. Using mass spectroscopy and biostatistics analysis, the enrichment efficiency of different metal ions immobilized on mesoporous silica chips was investigated. The novel technology reported provides a platform capable of efficiently profiling the serum proteome for biomarker discovery, forensic sampling, and routine diagnostic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135976      PMCID: PMC3397147          DOI: 10.1039/c0nr00720j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  45 in total

1.  Clinical proteomics: written in blood.

Authors:  Lance A Liotta; Mauro Ferrari; Emanuel Petricoin
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

2.  Phosphoproteomic analysis using immobilized metal ion affinity chromatography on the basis of cellulose powder.

Authors:  Isabel Feuerstein; Sandra Morandell; Guenther Stecher; Christian W Huck; Taras Stasyk; Hong-Lei Huang; Lukas A Huber; Guenther K Bonn
Journal:  Proteomics       Date:  2005-01       Impact factor: 3.984

Review 3.  Phosphoproteome analysis.

Authors:  Roberto Raggiaschi; Stefano Gotta; Georg C Terstappen
Journal:  Biosci Rep       Date:  2005 Feb-Apr       Impact factor: 3.840

4.  Development of phosphopeptide enrichment techniques for phosphoproteome analysis.

Authors:  Guanghui Han; Mingliang Ye; Hanfa Zou
Journal:  Analyst       Date:  2008-08-01       Impact factor: 4.616

Review 5.  Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry.

Authors:  Jamie D Dunn; Gavin E Reid; Merlin L Bruening
Journal:  Mass Spectrom Rev       Date:  2010 Jan-Feb       Impact factor: 10.946

6.  Different phosphorylation states of the anaphase promoting complex in response to antimitotic drugs: a quantitative proteomic analysis.

Authors:  Judith A J Steen; Hanno Steen; Ann Georgi; Kenneth Parker; Michael Springer; Marc Kirchner; Fred Hamprecht; Marc W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-17       Impact factor: 11.205

Review 7.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

8.  Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Authors:  Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

9.  Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

Authors:  Mark G Kris; Ronald B Natale; Roy S Herbst; Thomas J Lynch; Diane Prager; Chandra P Belani; Joan H Schiller; Karen Kelly; Harris Spiridonidis; Alan Sandler; Kathy S Albain; David Cella; Michael K Wolf; Steven D Averbuch; Judith J Ochs; Andrea C Kay
Journal:  JAMA       Date:  2003-10-22       Impact factor: 56.272

10.  Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.

Authors:  Mohamed Bentires-Alj; Benjamin G Neel
Journal:  Cancer Res       Date:  2007-03-08       Impact factor: 12.701

View more
  10 in total

Review 1.  Recent advances in enrichment and separation strategies for mass spectrometry-based phosphoproteomics.

Authors:  Chenxi Yang; Xuefei Zhong; Lingjun Li
Journal:  Electrophoresis       Date:  2014-06-16       Impact factor: 3.535

2.  Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.

Authors:  Jia Fan; Muy-Kheng M Tea; Chuan Yang; Li Ma; Qing H Meng; Tony Y Hu; Christian F Singer; Mauro Ferrari
Journal:  J Proteome Res       Date:  2016-04-26       Impact factor: 4.466

3.  Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series.

Authors:  Xu Qian; Duc T M Nguyen; Yaojun Li; Jianxin Lyu; Edward A Graviss; Tony Y Hu
Journal:  Tuberculosis (Edinb)       Date:  2016-09-28       Impact factor: 3.131

Review 4.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

5.  Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.

Authors:  Jia Fan; Yi Huang; Inez Finoulst; Hung-Jen Wu; Zaian Deng; Rong Xu; Xiaojun Xia; Mauro Ferrari; Haifa Shen; Ye Hu
Journal:  Cancer Lett       Date:  2012-11-27       Impact factor: 8.679

6.  Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer.

Authors:  Yaojun Li; Yueguo Li; Tao Chen; Anna S Kuklina; Paul Bernard; Francisco J Esteva; Haifa Shen; Mauro Ferrari; Ye Hu
Journal:  Clin Chem       Date:  2013-10-21       Impact factor: 8.327

7.  Monitoring the progression of metastatic breast cancer on nanoporous silica chips.

Authors:  Jia Fan; Xiaoyong Deng; James W Gallagher; Haiyu Huang; Yi Huang; Jianguo Wen; Mauro Ferrari; Haifa Shen; Ye Hu
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2012-05-28       Impact factor: 4.226

8.  Circulating peptidome to indicate the tumor-resident proteolysis.

Authors:  Zaian Deng; Yaojun Li; Jia Fan; Guohui Wang; Yan Li; Yaou Zhang; Guoping Cai; Haifa Shen; Mauro Ferrari; Tony Y Hu
Journal:  Sci Rep       Date:  2015-03-19       Impact factor: 4.379

9.  Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure.

Authors:  Kai Liang; Hongmei Wu; Tony Y Hu; Yan Li
Journal:  Clin Proteomics       Date:  2016-11-22       Impact factor: 3.988

10.  Smart polymers driven by multiple and tunable hydrogen bonds for intact phosphoprotein enrichment.

Authors:  Xiaofei Zhang; Qi Lu; Cheng Chen; Xiuling Li; Guangyan Qing; Taolei Sun; Xinmiao Liang
Journal:  Sci Technol Adv Mater       Date:  2019-07-15       Impact factor: 8.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.